Molly Henderson Net Worth & Insider Trades

Molly Henderson - Chief Financial Officer, Urogen Pharma Ltd

As of February 2, 2022

What is Molly Henderson's Net Worth?

The current estimated net worth of Urogen Pharma Ltd's Chief Financial Officer, Molly Henderson, is estimated to be about $NaN . Molly Henderson owns about 5,248 units of Urogen Pharma Ltd common stock. In the last 2 years at Urogen Pharma Ltd, Molly Henderson has sold an estimated value of $33.63K worth.

What is Molly Henderson's Past Insider Trading?

Molly Henderson's largest purchase order was 2,500 units , worth over $39.63K on May 18, 2021. Molly Henderson's largest sale order was 2,587 units , worth over $31.12K on December 2, 2021. In total, Molly Henderson has made about 6 transactions over 2 years of their time at Urogen Pharma Ltd. Molly Henderson usually trades in February, with the busiest year in 2021. The most recent transaction was a sale order of 331 units , worth over $2.51K on February 2, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Molly Henderson's Salary in 2020?

As Chief Financial Officer of Urogen Pharma Ltd, Molly Henderson has a total base salary of $94,269 . Molly Henderson received compensation valued at about $1,362,230 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of a bonus of $100,000 , stock awards of $294,900 , option awards of $787,994 , other earnings, plans or compensations of $69,875 , and other compensation of $15,192 .

What is Molly Henderson's' Mailing Address?

  • Mailing address is 305 College Road East Princeton NJ 08540 NJ

Urogen Pharma Ltd Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Elizabeth Barrett 2020 $636,987 $0 $441,150 $876,164 $468,650 $43,716 $2,466,667
Elizabeth Barrett 2019 $694,697 $300,000 $15,082,782 $8,979,216 $840,000 $4,128 $25,900,823
Molly Henderson 2020 $94,269 $100,000 $294,900 $787,994 $69,875 $15,192 $1,362,230
Peter P. Pfreundschuh 2020 $324,329 $0 $176,460 $292,055 $218,800 $152,313 $1,163,956
Peter P. Pfreundschuh 2019 $435,625 $0 $212,500 $436,108 $261,375 $1,183 $1,346,791
Peter P. Pfreundschuh 2018 $156,424 $0 $527,875 $1,704,505 $96,800 $197 $2,485,800
Stephen L. Mullennix 2020 $139,311 $0 $88,230 $292,055 $140,200 $246,581 $906,376
Stephen L. Mullennix 2019 $435,625 $0 $212,500 $436,108 $261,375 $904 $1,346,512
Stephen L. Mullennix 2018 $359,754 $70,000 $1,102,893 $2,552,946 $223,400 $575 $4,309,568
Mark Schoenberg 2020 $185,026 $0 $176,460 $292,054 $293150 $1,767 $948,458
Mark Schoenberg 2019 $205,000 $0 $106,250 $218,054 $270,000 $1,604 $800,908
Mark Schoenberg 2018 $200,000 $0 $0 $0 $100,000 $0 $300,000
Jason Smith 2020 $126,930 $100,000 $491,500 $785,242 $92,083 $19,518 $1,615,274
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1668243/000156459021021330/urgn-def14a_20210607.htm

What are Urogen Pharma Ltd's Past Insider Trades?

Urogen Pharma Ltd's most recent insider trade came on May 3, 2022 by Mark Schoenberg who sold 254 units worth $1.68K . In the last 5 years, insiders at Urogen Pharma Ltd have sold an estimated value of $9.72M and bought an estimated value of $1.59M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Mark Schoenberg, Chief Medical Officer,  Elizabeth Barrett, Chief Executive Officer,  and Peter Pfreundschuh, Chief Financial Officer .

UroGen Pharma Ltd. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1